Skip to Main Content

Paper Details

Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies.
Vaccines (Basel)
5
2020
CR9114, HA, HA stalk domain, IgG anti-stalk antibody, Influenza A Virus Group, Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies, anti, anti-stalk antibody, chimeric cH6/1 hemagglutinin, hemagglutinin, human, mini-hemagglutinin, mini-hemagglutinin (HA) headless construct #4900, monoclonal antibodies KB2, mouse
Author NameAffiliation
Lynda CoughlanIcahn School of Medicine at Mount Sinai
Teresa AydilloIcahn School of Medicine at Mount Sinai
Teresa AydilloGlobal Health and Emerging Pathogens Institute
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinai
Adolfo Garc??a-SastreGlobal Health and Emerging Pathogens Institute
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinai
Adolfo Garc??a-SastreThe Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Adrian B McDermottVaccine Research Center (VRC), National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
Sandeep NarpalaVaccine Research Center (VRC), National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
  • 1 - 9

Datasets

Release 1.2